Skip to main content

Table 1 Baseline Demographics and Risk Factors (Full Analysis Seta)

From: Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab

Parameters

Details

Age in years, Mean (SD)

62.8 (9.36)

Age groups

 Between 18 and 64

53 (53%)

 Between 65 and 74

37 (37%)

 Between 75 and 84

9 (9%)

 85 and above

1 (1%)

Gender

 Male

57 (57%)

 Female

43 (43%)

 Ethnicity and Race

Indian (Asian)

Risk Factors

 Hypertension

66%

 Diabetes Mellitus

35%

 Dyslipidemia

11%

 Thyroid disease

10%

 Smokers

10 (10%)

  1. aFAS Full Analysis Set comprised all patients who provided informed consent and were treated with ranibizumab in this study. (N = 100)